BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SenzaGen
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260506T160000
DTEND;TZID=Europe/Stockholm:20260506T170000
DTSTAMP:20260917T051954
CREATED:20260421T130457Z
LAST-MODIFIED:20260504T180635Z
UID:36863-1778083200-1778086800@senzagen.com
SUMMARY:Webinar: In vitro skin sensitization potency assessment - Part 1
DESCRIPTION:New GARD® data on Fragrances\, Complex Mixtures\, and Biopesticides\nJoin us for the first webinar in a series focusing on in vitro skin sensitization potency assessment. In this opening session\, we will address common challenges in potency testing and highlight new GARD® data generated through scientific collaborations with dōTERRA and Bayer\, recently presented at the 2026 SOT Annual Meeting. \nYou will gain insight into typical use scenarios for GARD® skin Dose-Response\, and learn how this single-assay method\, based on genomics and machine-learning technology\, supports critical decision-making during product development\, including how to: \n\nDefine safe dose levels for materials with expected sensitizing potential.\nDerive reference NESIL values to support confirmatory human patch testing.\nEstablish a Point-of-Departure (PoD) for quantitative risk assessment.\n\nWith broad applicability to complex mixtures and novel raw materials with challenging properties\, GARD® provides a powerful non-animal solution for assessing skin sensitization potency. \n  \n \nKey topics\n\nIntroduction to the genomics and machine-learning based GARD® technology for quantitative skin sensitization potency assessment.\nCommon challenges in deriving PoDs and establishing safe dose levels for skin sensitizers.\nCase studies on Fragrances\, Complex Mixtures\, and Biopesticides.\n\nThe webinar will last around 30 minutes\, followed by a live Q&A. If you cannot attend the live event\, make sure to register to get access to the recording. \nSpeakers\n \nAndy Forreryd\, PhD\nScientific Liaison Manager @ SenzaGen \n\nCo-developer of the GARD®skin assay (OECD TG 442E).\nMember of the ISO/TC 194/WG 8 on irritation and sensitization.\nMember of OECD expert group on respiratory sensitization.\n\n \nTim Lindberg\, PhD\nGARD® expert @ SenzaGen \n\nCo-developer of the GARD®skin assay (OECD TG 442E).\nExperienced scientist within immunology\, genomics\, and in vitro assay development.\n\n 
URL:https://senzagen.com/event/2026-webinar-in-vitro-skin-sensitization-potency-assessment-part-1/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2025/01/Lime-UNIVERSAL-webinar.jpg
END:VEVENT
END:VCALENDAR